Research programme: Anti-GPCR antibodies - Ono Pharmaceutical/Monash University
Latest Information Update: 28 Oct 2024
At a glance
- Originator Monash University
- Developer Monash University; Ono Pharmaceutical
- Class Antibodies
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders